Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia

OBJECTIVES: Cefotaxime-resistant Enterobacteriaceae (CE) infections are intractable, with limited treatment options. Though carbapenems are frequently prescribed for CE infections, the emergence of carbapenem-resistant Enterobacteriaceae is of huge concern. Flomoxef is effective against CE in vitro,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chen-Hsiang, Chen, I-Ling, Li, Chia-Chin, Chien, Chun-Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826091/
https://www.ncbi.nlm.nih.gov/pubmed/29503575
http://dx.doi.org/10.2147/IDR.S146923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5826091/
https://www.ncbi.nlm.nih.gov/pubmed/29503575
http://dx.doi.org/10.2147/IDR.S146923

Ejemplares similares